Resources Contact Us Home
Binding peptides for carcinoembryonic antigen (CEA)

Image Number 5 for United States Patent #7438890.

The present invention provides binding moieties for CEA, which have a variety of uses wherever detecting, isolating or localizing CEA, and particularly CEA as opposed to cross-reactive antigens such as NCA, is advantageous. Particularly disclosed are synthetic, isolated polypeptides capable of binding CEA, which is overexpressed in adenocarcinomas of endodermally derived digestive system epithelia and fetal colon. Such polypeptides and disclosed derivatives are useful, e.g., as imaging agents for CEA-expressing tumors.

  Recently Added Patents
System and method for indoor-outdoor scene classification
Method for measuring IP network performance and controlling QoS, and apparatus and system thereof
Enhancement of live and simulated participant interaction in simulators
Stress barrier structures for semiconductor chips
LED light bulb providing high heat dissipation efficiency
Seal with stacked sealing elements
Modular high voltage distribution unit for hybrid and electrical vehicles
  Randomly Featured Patents
Tube bundle heat exchanger of constant temperature gradient for thermophoretic deposition of aerosol particles
Semiconductor device
Device for measuring coefficient of friction
Vehicle, toy, and/or replicas thereof
Multi-directional mirror device and method for optical inspection and autofocus measurement of objects
Surgical hair implanter
Multiple mode mobile device
Database query optimization using weight mapping to qualify an index
Method of forming multilayer diffusion barrier for copper interconnections